What drove NOVN.SW stock movement on Feb 04 2026?

Share movement on 04 Feb 2026 reflected earnings commentary, pipeline updates and above-average volume of **5,794,934** shares. Traders focused on Sandoz margin signs and management guidance for 2026.

What is Meyka AI’s short-term forecast for NOVN.SW stock?

Meyka AI's forecast model projects a monthly level of **CHF123.14**, implying about **+3.74%** upside from the close of **CHF118.70**. Forecasts are model-based and not guarantees.

How does NOVN.SW stock rank on valuation and yield?

Novartis trades at PE **20.69**, price-to-book near **6.62**, and offers dividend per share **4.51 CHF** for a yield near **2.99%**, showing a premium valuation with steady income.

What are the main risks to owning NOVN.SW stock?

Primary risks include generic pricing pressure at Sandoz, regulatory setbacks for pipeline drugs, and a current ratio under **1.0** which signals working-capital sensitivity.

CH Stocks

Novartis (NOVN.SW) ends SIX at CHF118.70 on Feb 04 2026: earnings set the tone

ByDanny Kontos February 5, 2026February 5, 2026

NOVN.SW stock closed on the SIX at CHF118.70 on 04 Feb 2026 after an earnings-related session that pushed the shares higher. The market priced in a modest upside as volume reached 5,794,934 shares, above the 50-day average of 2,967,625. Key numbers: EPS 5.65, PE 20.69, and dividend per share 4.51 CHF. Today’s close follows Novartis’s results and commentary that traders parsed for 2026 guidance and Sandoz margin recovery signals.